文献速递临床试验与 GCP真实世界研究与卫生经济

现代试验在兼具实用性与解释性时最为有用——不存在连续谱

Modern trials are most useful when they are pragmatic and explanatory - there is no continuum.
PubMed 文献 · J Clin Epidemiol · 2024-10-11

该评论文章回顾Schwartz与Lellouch提出的实用性与解释性试验设计概念,分析将二者视为连续谱的局限性。作者结合常规收集的真实世界数据、去中心化试验技术和数字生物标志物等新技术,论证实用性与解释性应作为两个独立但兼容的概念维度,从而在同一试验中并行回答两类问题。

要点

  • 实用性与解释性并非连续谱的两端,而是两个独立且兼容的概念维度。
  • 常规收集的真实世界数据、去中心化试验技术和数字生物标志物使同一试验并行回答两类问题成为可能。
  • 作者将解释性设计特征分为根本性、侵入性或非侵入性、充分或不充分。

核心结论

  • 实用性与解释性应被理解为两个独立但兼容的概念维度,而非连续谱的两端。
  • 现代试验设计可在同一试验中并行回答实用性与解释性问题,从而做出更好的临床与监管决策。

研究设计与样本

  • 本文为评论文章,基于对连续谱概念的分析,回顾关键试验设计特征并提出新概念框架。

主要发现

  • 常规收集的真实世界数据、去中心化试验技术和数字生物标志物可在对真实世界诊疗最小或无干扰的情况下观察健康结局。
  • 作者将解释性设计特征分为根本性、侵入性或非侵入性、充分或不充分,并描述其对实用性与解释性的影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Over half a century ago, the terms "pragmatic" and "explanatory" were introduced to biomedicine by Schwartz and Lellouch, presenting two distinct conceptual approaches to trial design. Today, we frequently say that there are pragmatic trials and there are explanatory trials. Pragmatic trials inform decision-making in practice, and explanatory trials aim to understand the mechanism of an intervention. They are often perceived as diametral extremes of a continuum. In this commentary, we argue that with the digitalization of health care and clinical research, ways for modern trial designs were paved and new avenues opened, and that there is no such continuum. METHODS, RESULTS AND CONCLUSIONS: Since the groundbreaking work of Schwartz and Lellouch, new approaches and methods have become available that allow researchers to address pragmatic and explanatory questions in parallel in the same trial. Emerging availability of routinely collected "real-world" data, development of decentralized trial techniques, and creation of digital biomarkers allow to observe health outcomes with minimal or no interference in real-world care. This overcomes previous limitations to studying mechanisms of interventions in routine care and makes the idea of a continuum obsolete. We argue that pragmatism and explanatorism need to be understood as two distinct but compatible conceptual dimensions to open new perspectives for using novel technologies to design the most informative clinical trials and make better clinical and regulatory decisions. We base our argument on an analysis of the concept of a continuum and highlight its limitations. We review key trial design features and introduce a new concept that sees explanatory design features as fundamental, invasive or noninvasive, or sufficient or insufficient. We describe their impact on pragmatism and explanatorism and show how multidimensional pragmatic explanatory trials that are most useful are possible today.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Janiaud P, Hemkens LG. Modern trials are most useful when they are pragmatic and explanatory - there is no continuum. J Clin Epidemiol. 2024. PMID: 39396584. doi:10.1016/j.jclinepi.2024.111566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。